Lifeboat Foundation

As edible, affordable lab-grown meat remains out of reach, a tiny start-up might have found a faster route to dinner tables.

When one thinks of Mark Twain, one thinks of folksy wit, Huckleberry Finn, Tom Sawyer and the Mississippi River. Twain’s work immortalized the rapidly changing United States of the 1800s. But in his personal life, Twain often preferred the future to nostalgia, supporting women’s suffrage and civil rights, and frequently being contemptuous of what he considered to be the absurd and corrupt values of the past. He harbored a long running fascination with technology and new gadgets, and frequently invested in the latter — albeit with spotty success, at best. But Twain cemented his becoming an honorary futurist via his long friendship with inventor and Mad-scientist archetype Nikola Tesla.

Follow us on social media:
Twitter / Facebook / Instagram

NEWPORT BEACH, Calif., July 12, 2017 /PRNewswire/ — Strathspey Crown LLC, a lifestyle healthcare company focused in ophthalmology, medical aesthetic and elective technologies and procedures, today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 9,662,199 covering an implantable intraocular lens with an optic (including accommodating, multifocal and phakic configurations), a camera and an LED display, and a communications module that wirelessly transmit and receive information from an external device (e.g. PDA).

Robert Edward Grant, Founder and Chairman of Strathspey Crown LLC commented, “Video cameras are now a standard feature of smart phone technology and wearable cameras have become popularized by companies like Google and Snap in recent years. This patent represents a significant step forward in the rapidly growing sector of human cyborg technology. The eye, as a transparent medium for light, is ideal for advanced and rechargeable implantables that enable video capture of all of life’s experiences. Our broader vision is to develop ground-breaking medical-grade ocular smart implantables that integrate cellular, WIFI and 802.11 transmissions in an elegant cognitive interface that we believe will enhance human intelligence, augment perceived reality, and digitally capture experiences and individual memories. We look forward to several continuations and expansions on this important intellectual property portfolio.”

Grant further commented, “Although Samsung, Sony and Google have all recently filed patent applications related to the same field, Strathspey Crown is thus far the only company to hold an issued patent in this promising ocular smart implant category. Our first camera-integrated acrylic IOLs will be completed in 2018, upon which we plan to pursue an FDA Investigational Device Exemption (IDE) and subsequent Pre-Market Approval (PMA) and related clinical trial.”

Brain-controlled computers are currently helping paralyzed patients, but one day they might be used to control everything around you.

The ability to control the world around you with only your mind has been a feature of some of the best science fiction stories ever written, but even today the idea sounds pretty futuristic. Still, neuroscientists around the world are hard at work trying to figure out how to make a digital interface for the brain and in recent years have made remarkable strides toward this goal. Although this technology is still in its infancy, it’s not quite as hard to imagine abandoning touch screens for mind control anymore.

For the most part, brain-computer interfaces (BCIs) are currently being created only for people who have suffered debilitating injuries that left them partially or completely paralyzed.

Continue reading “How We’ll Eventually Control Everything With Our Minds” »

A system that lets robots sense the difference between hot and cold has been developed.

Researchers at MIT’s Center for Extreme Bionics are engaged in a $100 million, five-year project with a goal to end disability worldwide.

This startup has built a brain-machine interface that enables mind control of machines—no implants required.

MIT’s Center for Extreme Bionics it trying to eliminate human disabilities and push us beyond the limits of our own bodies.

PCSK9 inhibitors, a new type of therapy, has arrived and appear to be an effective therapy for lowering LDL cholesterol to a level that exceeds the current standard of care.

Recently, the results from a clinical trial at Brigham and Women’s Hospital showed that the drug evolocumab, when combined with statins, significantly and safely reduced the risk of cardiovascular events.